ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $928,000 | +472.8% | 5,391 | +217.9% | 0.02% | +155.6% |
| Q2 2020 | $162,000 | +1925.0% | 1,696 | +987.2% | 0.01% | – |
| Q4 2019 | $8,000 | +300.0% | 156 | +164.4% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 59 | -3.3% | 0.00% | – |
| Q2 2019 | $3,000 | -97.9% | 61 | -98.0% | 0.00% | -100.0% |
| Q1 2019 | $145,000 | -88.6% | 3,109 | -86.0% | 0.01% | -89.2% |
| Q3 2018 | $1,274,000 | +129.5% | 22,263 | +94.7% | 0.07% | +111.4% |
| Q2 2018 | $555,000 | +2821.1% | 11,437 | +2187.4% | 0.04% | +1066.7% |
| Q1 2015 | $19,000 | -44.1% | 500 | -50.0% | 0.00% | -25.0% |
| Q2 2014 | $34,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |